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a  b  s  t  r  a  c  t
Pyrethroids  are  neurotoxic  insecticides  that  exert their  effects  by  prolonging  the open  time  of sodium
channels,  which  increases  the  duration  of  neuronal  excitation.  -cypermethrin  (CM)  is  derived  from  the
8-stereoisomers  that  together  make  up  the  pyrethroid  cypermethrin,  which  is one  of the  most  common
pyrethroids  being  used  in  agriculture  throughout  the  world.  The  objective  of this  study  was  to  character-
ize  the  occupational  exposure  to CM  in  a cohort  of Egyptian  agriculture  workers  (n = 37)  before,  during
and  after  6–10  consecutive  days  of application  of CM  to  cotton  ﬁelds.  Daily  spot  urine  specimens  were
collected  and analyzed  by GC-MS  NCI  for the CM metabolites  3-phenoxybenzoic  acid  (3-PBA)  and  cis-
3-(2′,2′-dichlorovinyl)-2,2-dimethylcyclopropane  carboxylic  acid (cis-DCCA).  Prior  to CM  application,
median  urinary  levels  of  3-PBA  (4.59  nmol/g  creatinine)  were  greater  than cis-DCCA  (0.33  nmole/g  creat-
inine)  demonstrating  low  background  exposures  to  pyrethroids.  During  the  application  period  for  CM,
median  urinary  levels  of  both  biomarkers  increased  (13.44  nmol  3-PBA/g  creatinine  and  7.76 nmol  cis-
DCCA/g  creatinine)  and  ranged  from  2.3–93.96  nmol  3-PBA/g  creatinine  and  0.09–90.94  nmol  cis-DCCA/g
creatinine,  demonstrating  that  workers  had  a wide  range  of  exposures  to  CM.  The data  also  demonstrate
that  pesticide  applicators  had  greater  exposures  to CM  than  workers  who  play a  supporting  role  in  the
seasonal  application  of pesticides  on the  cotton  crop.  Urinary  cis-DCCA  and  3-PBA  concentrations  were
elevated  at  7–11  days  after  the cessation  of  CM  application,  compared  to baseline  levels.  This  study  is
the  ﬁrst  to  use  these  biomarkers  to  quantify  occupational  exposures  speciﬁcally  to  CM. This urinary
biomarker  data  will  be  useful  for estimating  daily  internal  dose,  comparing  exposures  across  job  cat-
egories  within  the  Egyptian  pesticide  application  teams,  and  for  modeling  human  exposures  to  CM.
©  2013  Elsevier  GmbH.  All  rights  reserved.ntroduction
Pyrethroids are the most commonly utilized residential insec-
icides partly due to the generally held belief that they pose
inimal risk to human health. In addition, there are numerous
orldwide applications for pyrethroids in agriculture, horticul-ure, public health (hospitals and commercial aircraft) and textiles
Berger-Preiss et al., 2002; Wei  et al., 2012; Worthing and Hance,
991). They have insecticidal activity in their parent form and do
∗ Corresponding author at: Department of Pharmacology & Toxicology, University
t  Buffalo, 3435 Main Street, 102 Farber Hall, Buffalo, NY 14214, USA.
el.: +1 716 829 2319; fax: +1 716 829 2801.
E-mail address: jolson@buffalo.edu (J.R. Olson).
438-4639/$ – see front matter © 2013 Elsevier GmbH. All rights reserved.
ttp://dx.doi.org/10.1016/j.ijheh.2013.10.003not require metabolic activation to exert their neurotoxic effects,
which are mediated by increased open time of voltage-gated
sodium channels (Soderlund, 2012; Soderlund et al., 2002). The
initial symptoms of acute occupational pyrethroid intoxication
include parasthesia consisting of burning and itching sensations
on the skin or dizziness that develops approximately 4–6 h after
exposure, although dermal symptoms can manifest after min-
utes of application. Systemic symptoms (dizziness, headache,
nausea, anorexia and fatigue) can occur up to 48 h after acute
exposure (He et al., 1988, 1989; Vijverberg and Vandenbercken,
1990).Pyrethroids are classiﬁed as Type I or Type II pyrethroids. Type
I pyrethroids are esters of primary or secondary alcohols, whereas
Type II pyrethroids are esters of secondary alcohols with a cyano
group at the -carbon of the alcohol component. The acid and
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lcohol moieties both contain chiral centers, leading to the possibil-
ty of several stereoisomers for each pyrethroid, which may  exhibit
somer-speciﬁc insecticidal activity (Knaak et al., 2012; Leicht et al.,
996).
The type II pyrethroid, CM,  is derived from the 8-
tereoisomers that comprise the pyrethroid cypermethrin,
hich is one of the most common pyrethroids in agricultural
nd residential use. CM is a racemate of two cypermethrin
tereoisomers: (S)--cyano-3-phenoxybenzyl-(1R)-cis-3-(2,2-
ichlorovinyl)-2,2-dimethylcyclopropane carboxylate, and
R)--cyano-3-phenoxybenzyl-(1S)-cis-3-(2,2-dichlorovinyl)-
,2-dimethylcyclopropane carboxylate (Knaak et al., 2012), which
re considered the two most stable cis-isomers (Leicht et al., 1996;
iu et al., 2005). The major detoxiﬁcation pathway of CM is
hrough hydrolysis by esterases and hydroxylation by cytochrome
450s (Abernathy and Casida, 1973; Ross et al., 2006; Scollon et al.,
009). In vitro studies have shown that alcohol and aldehyde dehy-
rogenases can also contribute to the metabolism of pyrethroids
Choi et al., 2002). Dosing studies with CM and cypermethrin in 6
uman volunteers indicate an elimination half-life range of 8–22 h
or a single dermal exposure (Eadsforth et al., 1988; Woollen et al.,
992).
The assessment of human exposure to insecticides such as
yrethroids is often based on quantiﬁcation of metabolites excreted
n urine (Barr et al., 2010; Eadsforth et al., 1988; Elﬂein et al., 2003;
ortin et al., 2008; Hardt and Angerer, 2003; Kolmodin-Hedman
t al., 1982; Leng et al., 1996, 1997; Wang et al., 2007; Woollen
t al., 1992; Xia et al., 2008; Zhang et al., 1991). The major uri-
ary metabolites of CM in humans are 3-phenoxybenzoic acid
3-PBA) and cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane
arboxylic acid (cis-DCCA), which are conjugated prior to being
xcreted in the urine (Eadsforth et al., 1988; Leng and Gries,
005; Woollen et al., 1992) (Fig. 1). 3-PBA is a metabolite
ommon to a large number of pyrethroid insecticides, while cis-
CCA is a more speciﬁc metabolite and useful urinary biomarker
f exposure for CM,  permethrin and cyﬂuthrin (Barr et al.,
010; Hardt and Angerer, 2003; Heudorf and Angerer, 2001;
ang et al., 2007). Thus, urinary concentrations of 3-PBA may
erve as a general biomarker of pyrethroid exposure, while cis-
CCA represents a more speciﬁc biomarker for human exposure
o CM.
Currently, there are no published studies speciﬁcally assessing
he occupational exposure to CM.  One pyrethroid study investi-
ated occupational exposure in Chinese cotton workers spraying
eltamethrin, fenvalerate and a deltamethrin methamidophos
ixture (Zhang et al., 1991). Hardt and Angerer (2003) evalu-
ted occupational exposure in individual workers after applying
 mixture of up to 7 synthetic pyrethroids, including CM.
nother study described occupational exposure to permethrin
nd fenvalerate (Kolmodin-Hedman et al., 1982), and a number
f other studies have documented general pyrethroid expo-
ure in non-occupational settings utilizing 3-PBA as a general
iomarker of pyrethroid exposure (Barr et al., 2010; Fortin
t al., 2008; Heudorf and Angerer, 2001; Schettgen et al.,
002).
The primary objective of the present study was  to investigate
ccupational exposure to CM by quantitating the daily urinary
evels of cis-DCCA and 3-PBA before, during, and after the applica-
ion of CM in a cohort of Egyptian agriculture workers who were
praying CM on cotton ﬁelds daily for up to 10 consecutive days. A
iomonitoring study on a subset of this Egyptian agriculture worker
opulation determined that 94–96% of the dose was due to der-
al  exposure (Fenske et al., 2012). While chlorpyrifos exposure has
reviously been characterized in these individuals (Farahat et al.,
011), this is the ﬁrst study to describe a longitudinal assessment
f exposure to CM.nd Environmental Health 217 (2014) 538–545 539
Materials and methods
Chemicals
1,1,1,3,3,3,-Hexaﬂuoroisopropanol (HFIP), N,N-
diisopropylcarbodiimide (DIC), 3-Phenoxybenzoic acid (3-PBA
98%) and internal standard, 2-Phenoxybenzoic acid (2-PBA 98%)
were purchased from Sigma–Aldrich Corp (St. Louis, MO,  USA).
cis- and trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane
carboxylic acid (cis-DCCA 5.6% and trans-DCCA 92.7%) were
purchased from Chemservice (PA, USA).
Population and sampling
A detailed description of the study setting was previously
published (Farahat et al., 2011), and a previous chlorpyrifos
biomonitoring study on a subset of this Egyptian agriculture worker
population estimated that 94–96% of the dose was  due to der-
mal  exposure (Fenske et al., 2012). Brieﬂy, the present study was
conducted in Menouﬁa, one of 29 governorates in Egypt, which
is located in the Nile River Delta north of Cairo. Daily urine sam-
ples were collected from a cohort of 37 Ministry of Agriculture
workers which were divided into three job categories: (1) applica-
tors who spray the insecticide on the cotton crop with a backpack
mistblower sprayer; (2) technicians who  walk the ﬁelds with the
applicator in order to point out particular areas which need atten-
tion; and (3) engineers who  direct the work mainly from the edge of
the ﬁeld. These workers were assigned to 3 regions (designated as
ﬁeld stations) where CM was  sprayed daily in 3–5 h work shifts
for up to 10 consecutive days in the summer of 2008. The work-
ers provided daily spot urine samples before, during, and after the
insecticide application cycle. The urine samples used for analysis
were collected just prior to start of the work day, on 24 h intervals at
approximately 3 pm.  One technician (ﬁeld station 2) was  included
in the demographic analysis, but did not provide any urine speci-
mens during the pyrethroid application and was therefore excluded
from the current study. Samples were placed on wet ice in a cooler
and transported to Menouﬁa University (Shebin El-Kom, Egypt),
where they were stored at −20 ◦C until being shipped to the State
University of New York at Buffalo (Buffalo, NY, USA) on dry ice for
analysis. Creatinine concentrations were measured using the Jaffe
reaction (Fabiny and Ertingshausen, 1971); urinary cis-DCCA and 3-
PBA concentrations are expressed as micrograms or nanomoles per
gram creatinine. All protocols and questionnaires were approved
by Institutional Review Boards of Menouﬁa University and Oregon
Health & Science University, the institute administering the parent
grant that funded the ﬁeld studies.
Sample preparation and analysis
The sample extraction method was adapted from previously
described methods (Fortin et al., 2008; Leng and Gries, 2005). First,
urine samples were spiked with 2-PBA internal standard at a ﬁnal
concentration of 20 ng/ml of sample. The samples were then treated
with hydrochloric acid and hydrolyzed at 100 ◦C for 2 h to form free
conjugated metabolites. The urine samples were then subjected to
a liquid-liquid extraction with methyl tert-butyl ether, the organic
phase was  removed, concentrated under nitrogen, resuspended
in acetonitrile, derivitized with 1,1,1,3,3,3-Hexaﬂuoroisopropanol
(HFIP) and N,N-diisopropylcarbodiimide, and the HFIP-esters were
transferred to a microinjector vial. Sample analysis was  performed
using an Agilent GC 6890 gas chromatograph, a Hewlett Packard
6890 Series autoinjector, a Phenomenex Zebron ZB-5HT Inferno
column (30 m × 250 m, ﬁlm thickness 0.10 m)  coupled to an
Agilent 5973 inert Mass Selective Detector (MSD). The oven tem-
perature program was  held at 60 ◦C for 1 min  and ramped to 300 ◦C
540 S.T. Singleton et al. / International Journal of Hygiene and Environmental Health 217 (2014) 538–545
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eFig. 1. -Cypermethrin metabolic schem
t 10 ◦C per minute and then held at 300 ◦C for 5 min. The inter-
ace heater was  held at 250 ◦C for the duration of the program.
elium was used as the carrier gas (99.999%) with a ﬂow rate of
.2 ml/min in constant ﬂow mode. 1 l of sample was  injected in
plitless mode. The MSD  was operated in Selective Ion Mode (SIM)
sing negative chemical ionization. The GC retention times (in min)
or cis-DCCA, 3-PBA, and 2-PBA were 7.372, 12.094, and 11.886
espectively. The MS  SIM mode target ion 322 (m/z) was  used to
etect cis-DCCA; and ion 364 (m/z) was used for the detection of
oth 2-PBA and 3-PBA.
uality control
The analytical limit of detection (LOD) for cis-DCCA and 3-PBA,
as 0.054 and 0.22 ng/ml, respectively (US EPA MDL). A spiked
C sample was routinely run with the analytical samples and the
etabolite concentration was determined from a standard curve
or the peak area for the selective ion. The cis-DCCA standard curve
as linear from 0.056 ng/ml to 28 ng/ml with a correlation coef-
cient of 0.999, while the 3-PBA linearity was tested from 0.1 to
00 ng/ml with a correlation coefﬁcient of 1.000. Spiked samples
n = 6) consistently gave metabolite recoveries above 93% and the
ithin series relative standard deviations were 3.4% and 2.1% for
is-DCCA and 3-PBA, respectively.
stimated exposure
Assuming steady-state conditions, it is possible to estimate the
aily internal dose of CM in each worker utilizing the urinary con-
entration of the more speciﬁc CM metabolite cis-DCCA (per gram
reatinine) and the following equation (adapted from (Eadsforth
t al., 1988; Farahat et al., 2011; Fenske et al., 2012):
d = (DCCAc × Cd × IEF × MWratio)/BW (1)
here Dd = estimated daily dose (g/kg/day); DCCAc = creatinine-
djusted cis-DCCA concentration (g/g creatinine) for each
orker; Cd = daily creatinine clearance of 1.7 g creatinine/day
Farahat et al., 2011); IEF = incomplete excretion factor of
.0/0.46 based on a human CM dosing study (Eadsforth et al.,
988); MW ratio = molecular weight ratio of CM and cis-DCCA
416.3/209.07 = 1.99; and BW = body weight (kg). Weights of the
orkers (ranging from 65 to 88 kg) were utilized to estimate daily
xposure (internal dose).urinary metabolites cis-DCCA and 3-PBA.
Statistical analysis
Data analysis was  performed with IBM SPSS statistics ver-
sion 19. Urinary metabolite levels before, during, and after the
CM application period and the metabolite levels among the
applicators, technicians, and engineers were each compared using
the non-parametric Kruskal–Wallis 1-way ANOVA followed by
Mann–Whitney U post hoc analysis (alpha = 0.05). The correlation
of urinary cis-DCCA and 3-PBA excretion was  assessed by Pearson
product-moment correlation coefﬁcient. In situations where con-
centrations were below the analytical limit of detection (LOD), a
value equal to the LOD divided by the square root of 2 was  used
(Barr et al., 2010).
Results
Study population
Table 1 summarizes demographic data for the 2008 cohort of
Egyptian Ministry of Agriculture workers that applied CM dur-
ing the summer of 2008. Farahat et al. (2011) previously reported
the exposure of those workers to chlorpyrifos. Table 2 shows the
2008 pesticide application schedule consisted of daily application
of chlorpyrifos followed by -cypermethrin for 3 ﬁeld stations or
regions.
Urinary cis-DCCA and 3-PBA concentrations
Fig. 2 shows median urinary cis-DCCA and 3-PBA concentra-
tions (normalized to creatinine) stratiﬁed by job category for each
of the three ﬁeld stations (Q1, Q2, Q3). The error bars represent
the inter-quartile range. July 17 was chosen for baseline analysis
of urinary metabolite concentrations because this date was prior
to the start of the government regulated CM application for the
three ﬁeld stations. In the event that a urine sample was not avail-
able from a worker on July 17, the sample that was  collected one
or two  days prior to that date was  used for baseline analysis of
that particular worker. The 3 ﬁeld stations (Q1–Q3) demonstrate
3 distinct exposure scenarios, including different length of spray
period (Table 2) and peak urinary metabolite levels during the
application (Fig. 2 and Table 3). Of the 3 stations, Q1 had the
longest duration of daily CM application and Q2 had the high-
est median peak excreted levels of urinary metabolites cis-DCCA
and 3-PBA. Only 1 technician from Q2 provided samples during the
S.T. Singleton et al. / International Journal of Hygiene and Environmental Health 217 (2014) 538–545 541
Table  1
Demographic characteristics of 2008 cohort of Ministry of Agriculture workers (From Farahat et al., 2011).
Characteristic Applicators (n = 14) Technicians (n = 12) Engineers (n = 12) ANOVA p-value
Age (years) 25.1 ± 11.4 48.8 ± 3.8 46.3 ± 3.2 <0.0001
69.8 ±
79.5 ±
27.5 ±

b
a
t
a
m
F

2Height (cm) 169.5 ± 6.5 1
Weight (kg) 73.5 ± 14.6 
Body  mass index (kg/m2) 25.4 ± 3.7 
CM spray and this particular worker had very low urine levels of
oth cis-DCCA (<1 g/g creatinine) and 3-PBA (<2 g/g creatinine)
t all time points analyzed throughout the study. At the baseline,
here was no signiﬁcant difference in the median metabolite levels
mong the 3 job categories. When the application of CM began, the
edian urinary cis-DCCA and 3-PBA levels increased for all three
ig. 2. Urinary concentrations of cis-DCCA and 3-PBA in applicators, technicians, and eng
-cypermethrin application. Data are presented as median ± interquartile range (n = 2–5
,  where n = 1 technician) * = p < 0.001 for the difference between job categories. 5.0 172.8 ± 2.8 0.227
 9.7 81.6 ± 12.6 0.247
 2.4 27.3 ± 4.1 0.263
job categories, with the applicators having signiﬁcantly higher lev-
els during the spray period as compared to the engineers (Q1–Q3)
and technician (Q1 and Q3) (p < 0.001). In all three-ﬁeld stations,
the median urinary metabolite levels during the application period
followed the rank order: Applicator > Engineer > Technician. For
CM,  urinary metabolite concentrations decreased over the 7-day
ineers from ﬁeld stations 1, 2, and 3 in 2008. Shaded areas represent the period of
 workers for each job category in a ﬁeld station, with the exception of ﬁeld station
542 S.T. Singleton et al. / International Journal of Hygiene and Environmental Health 217 (2014) 538–545
Table 2
Daily application schedule for chlorpyrifos and -cypermethrin during the summer
of  2008.
Chlorpyrifos
application
-cypermethrin
application
Field stationa Start End Start End
Q1 1 July 17 July 19 July 28 July
A(n  = 5)
T(n  = 5)
E(n = 4)
Q2 6 July 14 July 19 July 26 July
A(n  = 4)
T(n  = 2)
E(n = 3)
Q3 7 July 14 July 19 July 24 July
A(n  = 5)
T(n  = 5)
E(n = 5)
e
p
g
(
P
h
u
p
∼
a
t
w
p
i
m
<
c
p
Table 4
Estimated daily internal dose of -cypermethrin in applicators prior to (baseline),
during (peak median), and post -cypermethrin application.
Median values Applicators
Field station Baseline Application Recovery
Q1 July 17 July 28 August 4
cis-DCCA (g/g creatinine) 0.15 10.89 2.09
Alpha-cypermethrin (g/kg/day) 0.01 0.97 0.19
Q2  July 17 July 25 August 4
cis-DCCA (g/g creatinine) <LOD 17.32 2.01
Alpha-cypermethrin (g/kg/day) – 1.53 0.18
Q3  July 17 July 22 August 4
T
Ma Region where cotton ﬁelds were sprayed daily by Ministry of Agriculture work-
rs;  A = applicators, T = technicians, E = applicators
ost-application period. cis-DCCA and 3-PBA concentrations were
enerally still elevated compared to baseline levels on August 4th
7–11 days after the cessation of CM application).
eak metabolite levels compared to baseline
For ﬁeld station 1 (Q1), all workers across all job categories
ad detectable levels of both cis-DCCA and 3-PBA in their baseline
rine sample. After the start of the CM application (July 19th),
eak median urinary cis-DCCA concentrations for Q1 showed a
70-fold increase for applicators, ∼86-fold increase for engineers,
nd ∼35-fold increase for technicians, when compared to respec-
ive median baseline values. Q1 urinary metabolite 3-PBA levels
ere detectable at baseline, and after the start of CM application
eak levels showed a ∼4-fold increase for applicators and a 3-fold
ncrease for engineers, and technicians, as compared to respective
edian baseline values.
In ﬁeld station 2, applicators baseline cis-DCCA levels were
LOD, and during the CM application period peak median
is-DCCA levels increased to 17.32 g/g creatinine. Engineers
eak median cis-DCCA levels during the CM application period
able 3
edian urinary cis-DCCA and 3-PBA levels prior to (baseline), during (peak), and post app
Baseline 
g/g  creatinine 
Field station cis-DCCA 3-PBA 
Applicator 1 0.15 2.85 
2  <LOD 0.90 
3  <LOD 0.85 
Engineer 1  0.07 1.41 
2  0.18 0.47 
3  0.19 1.43 
Technician 1  0.06 0.58 
2  <LOD <LOD 
3  0.01 0.78 
Baseline 
nmol/g creatinine 
Field Station cis-DCCA 3-PBA 
Applicator 1 0.74 13.31 
2  <LOD 4.19 
3  <LOD 3.96 
Engineer 1  0.32 6.60 
2  0.87 2.17 
3  0.90 6.66 
Technician 1  0.31 2.69 
2  <LOD <LOD 
3  0.03 3.62 cis-DCCA (g/g creatinine) <LOD 4.86 1.48
Alpha-cypermethrin(g/kg/day) – 0.43 0.13
increased ∼30-fold when compared to baseline values. Peak 3-PBA
levels in this ﬁeld increased ∼18-fold for applicators and ∼8-fold
for engineers.
Field station 3 had the shortest application period (6 days) as
well as the lowest peak levels of cis-DCCA and 3-PBA when com-
pared to the other two  ﬁeld stations. During the CM application,
peak cis-DCCA levels increased from <LOD to 4.86 g/g creatinine
for applicators, and ∼4-fold for both engineers and technicians.
Peak 3-PBA levels increased ∼6-fold for applicators, ∼2-fold for
engineers, and ∼2-fold for technicians, as compared to their respec-
tive median baseline values.
Correlation between cis-DCCA and 3-PBA
cis-DCCA and 3-PBA concentrations were compared in each
urine sample during the CM application period to determine
if there was  a correlation between the excreted levels of the 2
metabolites. Statistical analysis of the scatter plot in Fig. 3 found
a signiﬁcant positive linear correlation between daily urinary
concentrations of 3-PBA and cis-DCCA (Pearson correlation (95%
conﬁdence interval) r = 0.873 (0.815–0.935), n = 270 urine samples,
p < 0.001). The slope of the regression line = 0.76.Estimated daily dose of ˛CM
Table 4 summarizes daily CM dose estimates calculated from
peak median urinary cis-DCCA concentrations for applicators
lication of -cypermethrin.
Peak Post
g/g creatinine g/g creatinine
cis-DCCA 3-PBA cis-DCCA 3-PBA
10.89 11.11 2.09 5.68
17.32 15.78 2.01 2.93
4.86 4.69 1.48 3.48
6.05 4.32 0.90 2.92
5.36 3.97 1.09 1.35
0.84 2.26 0.71 1.40
2.00 1.99 1.15 3.25
0.93 2.26 0.67 1.53
0.65 1.44 0.19 1.71
Peak Post
nmol/g creatinine nmol/g creatinine
cis-DCCA 3-PBA cis-DCCA 3-PBA
52.10 51.84 9.99 26.52
82.84 73.68 9.64 13.66
23.26 21.91 7.09 16.22
28.94 20.18 4.28 13.63
25.64 18.55 5.20 6.29
4.00 10.55 3.40 6.54
9.55 9.27 5.52 15.18
4.44 10.55 3.18 7.16
3.10 6.70 0.93 7.99
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Eq. (1)). Applicators in ﬁeld station 2 had the highest peak median
is-DCCA levels 17.32 g/g creatinine, which corresponds to an
stimated CM dose of 1.52 g/kg bw/day (Table 4).
iscussion
is-DCCA and 3-PBA concentrations after daily ˛CM exposure
The Type II pyrethroid CM is metabolized by hydrolytic cleav-
ge of the ester bond to form the metabolite cis-DCCA, while
he alcohol moiety is further metabolized to 3-PBA likely by
xidative enzymes such as cytochrome P450s and aldehyde dehy-
rogenase (Choi et al., 2002; Godin et al., 2007; Scollon et al.,
009). Urinary levels of cis-DCCA and 3-PBA were measured in
he Egyptian cotton ﬁeld worker to estimate their exposure to
CM over the course of the spray schedule (pre-, during, and post-
pplication). The results show great variability from worker to
orker, even within the same job category. The 3 ﬁeld stations
Q1–Q3) demonstrate 3 distinct exposure scenarios, including dif-
erent length of spray period and peak metabolite levels during the
pplication. Accordingly, not all applicators were highly exposed,
hile several individual engineers and technicians were highly
xposed.
To our knowledge this is ﬁrst study to conduct a longitudi-
al assessment of occupational human exposure speciﬁcally to
CM.  This cohort is unique because the workers were applying
 single pesticide (CM)  for up to 10 consecutive days. Similar
o the previously reported occupational exposure to chlorpyrifos
xposure in this cohort (Farahat et al., 2011), applicators had the
ighest levels of urinary metabolites and thus greater exposure to
he parent compound, while technicians and engineers had lower
xposures.
orrelation between cis-DCCA and 3-PBAThe CM exposure characterization included analysis of the
ore speciﬁc urinary metabolite cis-DCCA, and the less speciﬁc,
-PBA, which is a more general biomarker of exposure to manynd Environmental Health 217 (2014) 538–545 543
pyrethroids exposure (Barr et al., 2010; Fortin et al., 2008; Heudorf
and Angerer, 2001; Schettgen et al., 2002). This approach allows for
a more robust characterization of the exposure to CM, the only
pyrethroid applied by the occupational cohort. The strong positive
linear correlation between the urinary levels of the two  metabolites
(nmoles/g creatinine) suggests that CM was  the only pyrethroid
that the workers were exposed to during this application. How-
ever, pre-spray baseline levels of 3-PBA were consistently higher
than pre-spray cis-DCCA levels, suggesting low level environmental
exposure to one or more other pyrethroids from which 3-PBA can
be derived as a urinary metabolite. The slope of the regression line
in Fig. 3 is 0.76, which indicates that the amount of 3-PBA excreted
during the aCM application was  76% of that for cis-DCCA and sug-
gests that the 3-PBA molecule is further metabolized to additional
metabolites that were not analyzed in this study. Hardt and Angerer
(2003) examined the relationship between 3-PBA and total DCCA
(the sum of cis and trans) excreted by pest control operators after
a single application of permethrin and found that the amount of
3-PBA was  approximately 54% the amount of total DCCA, which is
in line with our ﬁndings in the present study.
Comparison with other pyrethroid exposure studies
Although there are no other published studies on exposure
speciﬁcally to CM alone, our data can be compared to previous
studies of both non-occupational and occupational exposures to
several pyrethroids. In comparing the urinary concentrations of
the non-speciﬁc pyrethroid metabolite, 3-PBA, the Egyptian agri-
culture applicator’s peak urinary levels (mean 15.0 and median
15.8 g/g creatinine) are about 50 times greater than the levels
found in the 2010 US NHANES study of the general U.S. population
in 2001–2002 (geometric mean 0.324 g/g creatinine) (Barr et al.,
2010). Hardt and Angerer (2003) assessed background excretion of
urinary pyrethroid metabolites including (combined cis- and trans-
) DCCA from 45 urine samples in 25 women and men  in Germany
who had no occupational exposure to pesticides. These studies sug-
gest substantial non-occupational exposure to pyrethroids in the
general population. The mean DCCA urinary concentration found
in these samples was 0.8 g/g creatinine. The peak cis-DCCA con-
centrations in the Egyptian workers (mean 16.4, median 17.4 g/g
creatinine) were more than 20 fold higher than the levels in this
German population.
Biological monitoring was carried out in a population of German
agriculture workers involved in applications of various pyrethroid
insecticides, including CM (n = 19 workers, 24 urine samples)
(Hardt and Angerer, 2003). The mean cis-DCCA and 3-PBA concen-
trations found in these workers were 0.6 and 1.8 g/g creatinine,
respectively. These concentrations are also several fold lower than
the peak (during spray) levels observed in the Egyptian applicators.
Comparison to chlorpyrifos exposures in this cohort
During the summer of 2008, the Egyptian workers applied the
organophosphorus pesticide, chlorpyrifos, to the cotton ﬁelds prior
to the CM application. Farahat et al. (2011) estimated chlorpyri-
fos exposures in these workers using urinary TCPy as a biomarker
for chlorpyrifos. During the chlorpyrifos application, Farahat et al.
(2011) reported peak urinary TCPy levels on July 10 in ﬁeld station
1 (mean 14012, median 10505 g/g creatinine). This peak median
urinary TCPy level corresponds to estimated internal chlorpyrifos
dose of 578.4 g/kg/day. The peak median CM doses estimated in
the present study (1.52 g/kg BW/day) are several orders of mag-
nitude lower than the estimated chlorpyrifos doses in this cohort.
The route of exposure for chlorpyrifos in this occupational setting
is primarily dermal (Fenske et al., 2012) and because the applica-
tion method for both insecticides is the same (backpack mistblower
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prayers), it is plausible that the primary route of exposure for aCM
n this study is also dermal. Human dosing studies have shown that
here are differences between the elimination half-life and the der-
al  adsorption for CPF and aCM. Grifﬁn et al. (1999) and Meuling
t al. (2005) both reported average CPF elimination half-lives of
1 h and ∼1% adsorption, based upon the recovery of the applied
ose as urinary metabolites and the amount of chlorpyrifos recov-
red from the skin subtracted from the amount applied to the skin.
wo human dosing studies with aCM and cypermethrin calculated
n elimination half-life range of 8–22 h after the application of a
ingle dermal dose, and ∼0.1% of the applied dose was  recovered
s urinary metabolite DCCA (Eadsforth et al., 1988; Woollen et al.,
992). The variance between the half-life and the absorption of
PF and aCM can explain, in part, why the levels of the aCM urinary
etabolites cis-DCCA and 3-PBA did not reach the exceedingly high
evels as seen for the CPF urinary metabolite TCPy.
Several in vitro studies have shown that metabolism of
yrethroids is mediated by carboxylesterases (Crow et al., 2007;
ishi et al., 2006; Ross et al., 2006). Crow et al., 2007 demon-
trated that the activity of human carboxylesterase 1 and 2
hCE1 and hCE2) is inhibited after treatment with chlorpyrifos-
xon, the active metabolite of chlorpyrifos, and metabolism
ssays indicate that hydrolysis of trans-permethrin is inhib-
ted by chlorpyrifos-oxon in human liver fractions (Choi et al.,
004). The Egyptian agriculture workers were spraying chlorpyri-
os for up to 17 days just prior to the application of CM on
he cotton ﬁelds. Thus, there is potential for interactions in the
etabolism of chlorpyrifos and CM in vivo. Prior exposure to
hlorpyrifos could inhibit the carboxylesterases ability to detox-
fy CM,  thereby altering the pharmacokinetic and toxic potential
f CM.  Future studies designed to assess the interactive effects
f these two classes of insecticides will be critical in examin-
ng the impact of combined and sequential exposures on human
ealth.
Urinary cis-DCCA and 3-PBA concentrations were generally still
levated compared to baseline levels 7–11 days after the cessa-
ion of application (on August 4). This result was unexpected based
pon the reported mean urinary half-life of 13 h for aCM after a
ingle dermal exposure (Woollen et al., 1992). This ﬁnding may be
xplained by poor washing habits after handling the insecticide,
ontinued exposure from wearing CM drenched clothing, or by
orkers re-entering the cotton ﬁelds and contacting CM residue
n the cotton plants or in the soil. Another possible route of contin-
ed exposure is from skin or deep compartments such as fat tissue.
CM is highly lipophilic and the internalized compound may  get
nto skin layers where it is not readily removed by typical washing
rocedures (Eadsforth et al., 1988), and fat compartments where
t can be slowly released over time, metabolized, and excreted as
rinary cis-DCCA and 3-PBA. Another explanation for the accumu-
ation of urinary cis-DCCA and 3-PBA (Fig. 2) is the possibility that
he pharmacokinetics of aCM metabolism and excretion in man  are
ifferent from repeated and sustained exposure when compared to
he single dermal dose that was used to estimate the half life range
f 8–22 h (Woollen et al., 1992).
onclusion
This study is the ﬁrst longitudinal assessment of occupational
xposures speciﬁcally to the pyrethroid insecticide CM.  The
esults may  be utilized for future risk assessment efforts of CM.
hese ﬁndings will also be useful to inform the Egyptian agriculture
orkers of the extent of their exposures so that they may  take ade-
uate preventative measures to reduce exposure by implementing
he use of personal protective equipment and proper working prac-
ices.nd Environmental Health 217 (2014) 538–545
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